EIF4A2 and cancer: In following experiments it was shown that targeting the eIF4A subunit of eIF4F in human cancer xenograft tissues is sufficient to reduce tumor cell proliferation and that silvestrol (14) was the most active derivative from twelve benzofurans tested.